122 related articles for article (PubMed ID: 17243007)
1. Immunomodulation of the anti-islet CD8 T cell response by B7-2.
Yadav D; Sarvetnick N
J Clin Immunol; 2007 Mar; 27(2):221-6. PubMed ID: 17243007
[TBL] [Abstract][Full Text] [Related]
2. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
3. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
[TBL] [Abstract][Full Text] [Related]
4. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
5. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
7. B7-1 mediated costimulation regulates pancreatic autoimmunity.
Yadav D; Fine C; Azuma M; Sarvetnick N
Mol Immunol; 2007 Apr; 44(10):2616-24. PubMed ID: 17289146
[TBL] [Abstract][Full Text] [Related]
8. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
Gurlo T; Kawamura K; von Grafenstein H
J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
[TBL] [Abstract][Full Text] [Related]
9. A novel function of islet-derived CD8+T cells in initiating and developing autoimmune insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.
Amano K; Yokono K; Hasegawa Y; Taki T; Tominaga Y; Yoneda R; Nagata M; Kasuga M
Diabetes Res Clin Pract; 1995 Jun; 28(3):161-72. PubMed ID: 8529494
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
Akazawa S; Mackin L; Jhala G; Fynch S; Catterall T; Selck C; Graham KL; Krishnamurthy B; Pappas EG; Kwong CJ; Sutherland APR; Kay TWH; Brodnicki TC; Thomas HE
Diabetologia; 2021 Apr; 64(4):878-889. PubMed ID: 33483762
[TBL] [Abstract][Full Text] [Related]
11. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells.
Kurts C; Carbone FR; Krummel MF; Koch KM; Miller JF; Heath WR
Nature; 1999 Mar; 398(6725):341-4. PubMed ID: 10192335
[TBL] [Abstract][Full Text] [Related]
12. In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes.
Zhang Y; O'Brien B; Trudeau J; Tan R; Santamaria P; Dutz JP
J Immunol; 2002 Feb; 168(3):1466-72. PubMed ID: 11801690
[TBL] [Abstract][Full Text] [Related]
13. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
[TBL] [Abstract][Full Text] [Related]
14. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.
Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B
Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276
[TBL] [Abstract][Full Text] [Related]
15. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
16. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
17. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus.
Wang B; Gonzalez A; Benoist C; Mathis D
Eur J Immunol; 1996 Aug; 26(8):1762-9. PubMed ID: 8765018
[TBL] [Abstract][Full Text] [Related]
18. Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia.
Yantha J; Tsui H; Winer S; Song A; Wu P; Paltser G; Ellis J; Dosch HM
Diabetes; 2010 Oct; 59(10):2588-96. PubMed ID: 20522597
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses.
King C; Mueller Hoenger R; Malo Cleary M; Murali-Krishna K; Ahmed R; King E; Sarvetnick N
Nat Med; 2001 Feb; 7(2):206-14. PubMed ID: 11175852
[TBL] [Abstract][Full Text] [Related]
20. The use of idd congenic mice to identify checkpoints of peripheral tolerance to islet antigen.
Hamilton-Williams EE; Martinez X; Lyman M; Hunter K; Wicker LS; Sherman LA
Ann N Y Acad Sci; 2007 Apr; 1103():118-27. PubMed ID: 17376833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
